Sitagliptin in the Elderly.
Phase of Trial: Phase II
Latest Information Update: 14 Oct 2017
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 14 Mar 2014 According to ClinicalTrials.gov record, status changed from active no longer recruiting to completed.
- 10 Aug 2011 Planned end date changed from Dec 2011 to Dec 2013 as reported by ClinicalTrials.gov.
- 23 Sep 2010 Planned end date changed from 1 Dec 2008 to 1 Dec 2011 as reported by ClinicalTrials.gov.